Log in to your Inderes Free account to see all free content on this page.
Herantis Pharma
1.45 EUR +2.11%4,034 investors are following this company
Revenue
-
EBIT %
-
P/E
72.5
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
HRTIS
Daily low / high price
1.45 / 1.485
EUR
Market cap
29.23M EUR
Turnover
57.15K EUR
Volume
39K
Latest videos
Financial calendar
General meeting
24.04.2024
Interim report
22.08.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Skandinaviska Enskilda Banken | 14.6 % | 14.6 % |
Joensuun kauppa ja kone Oy | 10.2 % | 10.2 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Tone Kvåle | 25.01.2024 | 7,500EUR |
Tone Kvåle | 01.06.2022 | 7,140EUR |
Premium
This content is for our Premium customers only.
ShowingAll content types
Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders
Herantis Pharma published the Annual report for 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio